• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Alzamend Neuro Inc (NQ: ALZN )

    0.3900 -0.0060 (-1.52%)
    Streaming Delayed Price Updated: 12:48 PM EDT, Jul 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 36,477
    Open 0.3959
    Bid (Size) 0.3800 (1)
    Ask (Size) 0.4000 (2)
    Prev. Close 0.3960
    Today's Range 0.3707 - 0.4199
    52wk Range 0.1132 - 2.032
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    -57.61%
    -57.61%
    1 Month
    -32.76%
    -32.76%
    3 Month
    -56.67%
    -56.67%
    6 Month
    -60.09%
    -60.09%
    1 Year
    -23.26%
    -23.26%

    More News

    Read More
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    ALZN Stock Earnings: Alzamend Neuro Reported Results for Q2 2024
    Via InvestorPlace
    Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel
    From Alzamend Neuro, Inc.
    Via Business Wire
    EXCLUSIVE: Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Alzamend Neuro Announces Initial Closing of Private Placement
    From Alzamend Neuro, Inc.
    Via Business Wire
    Alzamend Neuro Halts Equity Offering Program, Prioritizing Shareholder Value Amid Strategic Shift, Shares Slide
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million
    From Alzamend Neuro, Inc.
    Via Business Wire
    Alzamend Neuro And 2 Other Stocks Under $5 Insiders Are Buying
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program
    From Alzamend Neuro, Inc.
    Via Business Wire
    Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    ALZN Stock Earnings: Alzamend Neuro Misses EPS for Q3 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    ALZN Stock Earnings: Alzamend Neuro Beats EPS for Q1 2024
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.